Key result
Amlodipine reduced clinic supine diastolic blood pressure compared to enalapril after 8 weeks of treatment.
Why the study?
Does amlodipine improve blood pressure reduction compared to enalapril in patients with moderate/severe hypertension?
RCT (n=31)
Observer-blind
minimisation
Does amlodipine improve blood pressure reduction compared to enalapril in patients with moderate/severe hypertension?
Amlodipine monotherapy provides a greater reduction in clinic diastolic blood pressure compared to enalapril in patients with moderate to severe hypertension over an 8-week period.
Answers are grounded in this paper and cite their sources.
May support either agent in moderate/severe hypertension; leaves open long-term comparative outcomes.
The safety and efficacy of amlodipine vs enalapril as monotherapy was evaluated in patients with moderate/severe hypertension (supine DBP 105-125 mm Hg, SBP 140-220 mm Hg). 2. After 2 weeks placebo treatment 31 patients were randomised by the technique of minimisation in an observer-blind study to receive once daily treatment with either amlodipine (15 patients) 5-10 mg, or enalapril (16 patients) 5-20 mg for 8 weeks. The study design concluded with 2 weeks placebo treatment. In addition to clinic measurements, home blood pressure monitoring (Copal UA-251) was performed during the study. 3. Clinic supine systolic blood pressure was reduced from 177 to 152 mm Hg (amlodipine) and 183 to 169 mm Hg (enalapril) (95% CI for the intergroup difference -22.1, 0.3, P = 0.06) after 8 weeks treatment. 4. Clinic supine diastolic blood pressure was reduced from 110 to 93 mm Hg (amlodipine) and 109-102 mm Hg (enalapril) (95% CI for the intergroup difference -17.7, -2.7, P < 0.01) after 8 weeks treatment. 5. Home blood pressure recordings confirmed these reductions in blood pressure. Although the reduction in blood pressure was greater for the amlodipine treated group, the differences between treatments were not statistically significant. 6. Both drugs were reasonably well tolerated. The adverse events occurring most frequently in the amlodipine group were headache (5), peripheral oedema (3), upper respiratory infection (3) and anxiety (2). The adverse events occurring most frequently in the enalapril treated patients were headache (6), dizziness (3) and upper respiratory infection (2).
No takes yet. Share an insight, caveat, or question.
Fowler et al. (1993) conducted an RCT in moderate/severe hypertension (n=31). Amlodipine vs. Enalapril (5-20 mg once daily) was evaluated on Clinic supine diastolic blood pressure (95% CI -17.7, -2.7, p=<0.01). Amlodipine reduced clinic supine diastolic blood pressure compared to enalapril after 8 weeks of treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: